Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Kees de Joncheere"'
Autor:
Christine Leopold, Aukje K Mantel-Teeuwisse, Sabine Vogler, Silvia Valkova, Kees de Joncheere, Hubert GM Leufkens, Anita K Wagner, Dennis Ross-Degnan, Richard Laing
Publikováno v:
Bulletin of the World Health Organization, Vol 92, Iss 9, Pp 630-640 (2014)
Objective To identify pharmaceutical policy changes during the economic recession in eight European countries and to determine whether policy measures resulted in lower sales of, and less expenditure on, pharmaceuticals. Methods Information on pharma
Externí odkaz:
https://doaj.org/article/0b891f917dda4eda8ffdf391758f1f06
Autor:
Swathi Iyengar, Kiu Tay-Teo, Sabine Vogler, Peter Beyer, Stefan Wiktor, Kees de Joncheere, Suzanne Hill
Publikováno v:
PLoS Medicine, Vol 13, Iss 5, p e1002032 (2016)
INTRODUCTION:New hepatitis C virus (HCV) medicines have markedly improved treatment efficacy and regimen tolerability. However, their high prices have limited access, prompting wide debate about fair and affordable prices. This study systematically c
Externí odkaz:
https://doaj.org/article/a0b2c94ed74a437a896c0dbd04e762ea
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 8, Iss sup1 (2015)
Externí odkaz:
https://doaj.org/article/3a12e2a291524d6389b4b4a31768674e
Autor:
Nicola Magrini, Jane Robertson, Gilles Forte, Bernadette Cappello, Lorenzo P Moja, Kees de Joncheere, Marie-Paule Kieny
Publikováno v:
Bulletin of the World Health Organization, Vol 93, Iss 4, Pp 283-284
Externí odkaz:
https://doaj.org/article/833e3ad9ccbb4f1f92bd4c10fd4ae77c
Autor:
Raymond Hutubessy, Marie Paule Kieny, Tessa Tan-Torres Edejer, Suzanne Hill, Kees de Joncheere, Jeremy A. Lauer, Melanie Y Bertram
Publikováno v:
Bulletin of the World Health Organization
Cost-effectiveness analysis is used to compare the costs and outcomes of alternative policy options. Each resulting cost-effectiveness ratio represents the magnitude of additional health gained per additional unit of resources spent. Cost-effectivene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e48c081ad517f65f0a27b4b49154ef0
https://doi.org/10.2471/blt.15.164418
https://doi.org/10.2471/blt.15.164418
Autor:
Nicola Magrini, Esteban Burrone, Dzintars Gotham, Andy Gray, Marie Paule Kieny, Charles Gore, Yehoda M. Martei, Kees de Joncheere
Publikováno v:
Bulletin of the World Health Organization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c92f3863b8c91d680d1ffdba2f576183
https://pubmed.ncbi.nlm.nih.gov/31384076
https://pubmed.ncbi.nlm.nih.gov/31384076
Publikováno v:
Health Policy and Technology. 3:139-148
Objective: To present the Pharmaceutical Pricing and Reimbursement Information (PPRI) initiative, as an illustrative example of an engagement with policy makers in the field of pharmaceutical pricing and reimbursement. Methods: The paper is based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c23cf83aed4e2dd3a3a3d11b8714f0c6
https://doi.org/10.1016/j.hlpt.2014.01.001
https://doi.org/10.1016/j.hlpt.2014.01.001
Autor:
Christine Leopold, Sabine Vogler, Hubert G. M. Leufkens, Kees de Joncheere, Richard Laing, A. K. Mantel-Teeuwisse
Publikováno v:
Health Policy. 112:209-216
Background Previous studies have suggested that medicines prices in Europe converge over time as a result of policy measures such as external price referencing. Objective To explore whether ex-factory prices of on-patented medicines in Western Europe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e93d52d3732dd6abe79957223bd858f3
https://doi.org/10.1016/j.healthpol.2013.08.012
https://doi.org/10.1016/j.healthpol.2013.08.012
Publikováno v:
Health policy (Amsterdam, Netherlands). 120(12)
Background Policy-makers can use a menu of pharmaceutical policy options. This study aimed to survey these measures that were implemented in European countries between 2010 and 2015. Methods We did bi-annual surveys with competent authorities of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6d98978937e1063f653b413600d29ba
https://pubmed.ncbi.nlm.nih.gov/27720165
https://pubmed.ncbi.nlm.nih.gov/27720165
Publikováno v:
Globalization and Health, Vol. 11 (2015) P. 18
Globalization and Health
Globalization and Health
Background In response to the global burden of non-communicable diseases (NCDs), the World Health Organization (WHO) has developed a Global Action Plan that includes a voluntary medicines target of 80% availability and affordability of essential medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4880395af55c49bb871e8433d03172a7
https://doi.org/10.1186/s12992-015-0105-0
https://doi.org/10.1186/s12992-015-0105-0